Cargando…

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

A genuine microbiota resides in the lungs which emanates from the colonization by the oropharyngeal microbiota. Changes in the oropharyngeal microbiota might be the source of dysbiosis observed in the lower airways in patients suffering from asthma or cystic fibrosis (CF). To examine this hypothesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutin, Sébastien, Depner, Martin, Stahl, Mirjam, Graeber, Simon Y., Dittrich, Susanne A., Legatzki, Antje, von Mutius, Erika, Mall, Marcus, Dalpke, Alexander H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763206/ https://www.ncbi.nlm.nih.gov/pubmed/29445257 http://dx.doi.org/10.1155/2017/5047403

Ejemplares similares

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis
por: Frey, Dario L., et al.
Publicado: (2022)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis
por: Metzger, Marisa I., et al.
Publicado: (2021)

Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients
por: Boutin, Sébastien, et al.
Publicado: (2017)

Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis
por: Boutin, Sébastien, et al.
Publicado: (2015)

Effects of lumacaftor—ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2–11 years
por: Berges, Julian, et al.
Publicado: (2023)

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
por: Yi, Buqing, et al.
Publicado: (2021)

TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease
por: Steinke, Eva, et al.
Publicado: (2023)

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis
por: Stahl, Mirjam, et al.
Publicado: (2021)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
por: Piehler, Linus, et al.
Publicado: (2023)

Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2021)

Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
por: Tony-Odigie, Andrew, et al.
Publicado: (2022)

Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study
por: Thee, Stephanie, et al.
Publicado: (2022)

Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2023)

Reply to Dournes et al.: Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis
por: Stahl, Mirjam, et al.
Publicado: (2021)

Comparative evaluation of the effect of different growth media on in vitro sensitivity to azithromycin in multi-drug resistant Pseudomonas aeruginosa isolated from cystic fibrosis patients
por: Sörensen, Michael, et al.
Publicado: (2020)

Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis
por: Rademacher, Jessica, et al.
Publicado: (2023)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
por: Wucherpfennig, Lena, et al.
Publicado: (2023)

Immune Response in Cystic Fibrosis: Interplay between the Host and Microbes
por: Boutin, Sébastien, et al.
Publicado: (2023)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
por: Leutz-Schmidt, Patricia, et al.
Publicado: (2023)

MMP-9 gene variants increase the risk for non-atopic asthma in children
por: Pinto, Leonardo A, et al.
Publicado: (2010)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2021)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Increased Inflammatory Markers Detected in Nasal Lavage Correlate with Paranasal Sinus Abnormalities at MRI in Adolescent Patients with Cystic Fibrosis
por: Chung, Jaehi, et al.
Publicado: (2021)

DMBT1 is upregulated in cystic fibrosis, affects ciliary motility, and is reduced by acetylcysteine
por: Kiefer, Alexander, et al.
Publicado: (2022)

ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
por: Mall, Marcus A.
Publicado: (2020)

Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease
por: Wagner, Claudius J., et al.
Publicado: (2016)

A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF
por: Thee, Stephanie, et al.
Publicado: (2021)

Corrigendum: Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells
por: Sörensen, Michael, et al.
Publicado: (2020)

Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells
por: Sörensen, Michael, et al.
Publicado: (2020)

Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases
por: Stahl, Mirjam, et al.
Publicado: (2020)

Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021)

Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
por: Knutsen, Alan P., et al.
Publicado: (2011)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
por: Balázs, Anita, et al.
Publicado: (2018)

Prenatal and childhood infections: implications for the development and treatment of childhood asthma
por: Fuchs, Oliver, et al.
Publicado: (2013)

What to expect of the first ERS/ECFS Adult Cystic Fibrosis Conference
por: Kisseleff, Jenai, et al.
Publicado: (2023)

The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations
por: Schedel, Michaela, et al.
Publicado: (2006)

The altered gut microbiota in adults with cystic fibrosis
por: Burke, D.G., et al.
Publicado: (2017)

Lung function and microbiota diversity in cystic fibrosis
por: Cuthbertson, Leah, et al.
Publicado: (2020)

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial
por: Stahl, Mirjam, et al.
Publicado: (2023)

Supplementation with Red Palm Oil Increases β-Carotene and Vitamin A Blood Levels in Patients with Cystic Fibrosis
por: Sommerburg, Olaf, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jen3me7bor72usmpe8h5e0hcsa